Hiroshima University Hospital

Hiroshima, Hiroshima 734-8551

4 studies enrolling now · 5 studies all time

What they study most

Interstitial Lung Diseases, Neoplasm Metastasis, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases, Systemic Sclerosis

Studies at this site

• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations — Recruiting now
• FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression — Starting soon
• Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) — Running, not enrolling